Huimin Du

866 total citations · 1 hit paper
30 papers, 484 citations indexed

About

Huimin Du is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Huimin Du has authored 30 papers receiving a total of 484 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 9 papers in Immunology and 7 papers in Molecular Biology. Recurrent topics in Huimin Du's work include Immune cells in cancer (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Sepsis Diagnosis and Treatment (4 papers). Huimin Du is often cited by papers focused on Immune cells in cancer (6 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Sepsis Diagnosis and Treatment (4 papers). Huimin Du collaborates with scholars based in China, United States and South Korea. Huimin Du's co-authors include Guosheng Ren, Bailin Niu, Ziying Yi, Long Wang, Jun Xie, Qing Guo, Xiaowei Chang, Jing Zhang, Jianping Gong and Changan Liu and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Scientific Reports.

In The Last Decade

Huimin Du

28 papers receiving 479 citations

Hit Papers

Noncoding RNAs in sepsis-associated acute liver injury: R... 2025 2026 2025 5 10 15
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Noncoding RNAs in sepsis-associated acute liver injury: Roles, mechanisms, and therapeutic applications
    2025 18 citations Jialian Wang, Xingyu Tao et al. Pharmacological Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huimin Du China 13 189 153 127 107 66 30 484
Li Cai China 11 232 1.2× 107 0.7× 129 1.0× 82 0.8× 72 1.1× 21 483
Lixia Xu China 15 292 1.5× 69 0.5× 77 0.6× 151 1.4× 37 0.6× 34 564
Kartik Gupta United States 10 352 1.9× 80 0.5× 116 0.9× 80 0.7× 64 1.0× 13 538
Yue Qiu China 14 175 0.9× 74 0.5× 145 1.1× 41 0.4× 66 1.0× 32 511
Kariman Chaba France 12 188 1.0× 256 1.7× 183 1.4× 101 0.9× 168 2.5× 13 644
Xiaoling Zhang China 10 140 0.7× 68 0.4× 111 0.9× 51 0.5× 43 0.7× 19 393
Keisuke Omori Japan 12 175 0.9× 76 0.5× 151 1.2× 51 0.5× 31 0.5× 17 548
Zheng Xu China 14 149 0.8× 108 0.7× 175 1.4× 55 0.5× 129 2.0× 34 514
Weizhe Zhong China 9 307 1.6× 74 0.5× 259 2.0× 95 0.9× 85 1.3× 12 548

Countries citing papers authored by Huimin Du

Since Specialization
Citations

This map shows the geographic impact of Huimin Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huimin Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huimin Du more than expected).

Fields of papers citing papers by Huimin Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huimin Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huimin Du. The network helps show where Huimin Du may publish in the future.

Co-authorship network of co-authors of Huimin Du

This figure shows the co-authorship network connecting the top 25 collaborators of Huimin Du. A scholar is included among the top collaborators of Huimin Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huimin Du. Huimin Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Jialian, Xingyu Tao, Pei-Feng Cheng, et al.. (2025). Noncoding RNAs in sepsis-associated acute liver injury: Roles, mechanisms, and therapeutic applications. Pharmacological Research. 212. 107596–107596. 18 indexed citations breakdown →
2.
Du, Huimin, et al.. (2025). Advances in Homing Peptide Targeted Therapies. International Journal of Peptide Research and Therapeutics. 31(3). 2 indexed citations
3.
Wang, Xiaoyu, Jiakui Li, Yushen Wu, et al.. (2025). AEBP1 drives fibroblast-mediated T cell dysfunction in tumors. Nature Communications. 16(1). 8171–8171.
4.
Tao, Xingyu, Jialian Wang, Yan Yuan, et al.. (2025). Optimal Sca-1-based procedure for purifying mouse adipose-derived mesenchymal stem cells with enhanced proliferative and differentiation potential. Frontiers in Cell and Developmental Biology. 13. 1566670–1566670. 4 indexed citations
5.
Wu, Tong, et al.. (2024). Exploring the association between hearing status and suicidal ideation among U.S. adults: An observational study. General Hospital Psychiatry. 92. 52–59. 1 indexed citations
6.
Yang, Qian, Liuying Li, Yuxian Wei, et al.. (2024). Novel prognostic biomarker TBC1D1 is associated with immunotherapy resistance in gliomas. Frontiers in Immunology. 15. 1372113–1372113. 6 indexed citations
7.
Yan, Jiexi, Chan Zhu, Huimin Du, et al.. (2024). Gut microbiota as a biomarker and modulator of anti-tumor immunotherapy outcomes. Frontiers in Immunology. 15. 1471273–1471273. 16 indexed citations
8.
Guo, Qiaosheng, Shi Tang, Xingzhu Ju, et al.. (2024). Identification of molecular subtypes for endometrial carcinoma using a 46-gene next-generation sequencing panel: a retrospective study on a consecutive cohort. ESMO Open. 9(10). 103710–103710. 2 indexed citations
9.
Yue, Jian, et al.. (2024). Palliative surgery versus non-surgery of the solitary metastatic lesion in De novo metastatic breast cancer: A SEER based study. Medicine. 103(25). e38651–e38651. 1 indexed citations
10.
Tao, Xingyu, Jialian Wang, Bin Liu, et al.. (2024). Plasticity and crosstalk of mesenchymal stem cells and macrophages in immunomodulation in sepsis. Frontiers in Immunology. 15. 1338744–1338744. 8 indexed citations
11.
Liu, Jiazhou, Yuxian Wei, Fan Li, et al.. (2024). Acetylation-dependent deubiquitinase USP26 stabilizes BAG3 to promote breast cancer progression. Cancer Letters. 597. 217005–217005. 3 indexed citations
12.
Du, Huimin, et al.. (2022). Developing a new sepsis screening tool based on lymphocyte count, international normalized ratio and procalcitonin (LIP score). Scientific Reports. 12(1). 20002–20002. 29 indexed citations
13.
Chen, Yuru, Jiazheng Sun, Jiazhou Liu, et al.. (2022). Pharmaceutical targeting Th2-mediated immunity enhances immunotherapy response in breast cancer. Journal of Translational Medicine. 20(1). 615–615. 31 indexed citations
14.
Zhang, Jing, et al.. (2021). Role of international normalized ratio in nonpulmonary sepsis screening: An observational study. World Journal of Clinical Cases. 9(25). 7405–7416. 10 indexed citations
15.
Du, Huimin, Qing Xu, Sheng Xiao, et al.. (2019). MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29. Life Sciences. 224. 1–11. 60 indexed citations
16.
Du, Huimin, et al.. (2019). The co-expression characteristics of LAG3 and PD-1 on the T cells of patients with breast cancer reveal a new therapeutic strategy. International Immunopharmacology. 78. 106113–106113. 68 indexed citations
17.
Niu, Bailin, et al.. (2012). Hath1 Inhibits Proliferation of Colon Cancer Cells Probably Through Up-regulating Expression of Muc2 and p27 and Down-regulating Expression of Cyclin D1. Asian Pacific Journal of Cancer Prevention. 13(12). 6349–6355. 2 indexed citations
18.
19.
Guo, Qing, Jun Xie, Xiaowei Chang, Xiaojin Zhang, & Huimin Du. (2001). Par-4 is a synaptic protein that regulates neurite outgrowth by altering calcium homeostasis and transcription factor AP-1 activation. Brain Research. 903(1-2). 13–25. 15 indexed citations
20.
Guo, Qing, Jun Xie, & Huimin Du. (2000). Par-4 induces cholinergic hypoactivity by suppressing ChAT protein synthesis and inhibiting NGF-inducibility of ChAT activity. Brain Research. 874(2). 221–232. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Li Cai Breakdown of academic impact, for papers by Lixia Xu Breakdown of academic impact, for papers by Kartik Gupta Breakdown of academic impact, for papers by Yue Qiu Breakdown of academic impact, for papers by Kariman Chaba Breakdown of academic impact, for papers by Xiaoling Zhang Breakdown of academic impact, for papers by Keisuke Omori Breakdown of academic impact, for papers by Zheng Xu Breakdown of academic impact, for papers by Weizhe Zhong
Rankless by CCL
2026